SOPHARMA (SPH): Notification - raport 43
Raport ESPI
UNI - EN REPORT No43/2016
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that the Board of Directors of Sopharma AD authorized the executive director of the company to enter into a contract for the sale of the shareholding of Sopharma AD in the capital of Ivanchich and Sons, Serbia. The transaction was concluded on May 9th, 2016 in Belgrade, Serbia. The parameters of the transaction are subject to confidentiality clauses in the interest of the all parties. Sopharma AD will continue its activities on the Serbian market through its daughter company Sopharma Trading AD.
